Column

Scalp Lesions of Collagen Disease and Lupus Behind Hair Loss — Dr. Moriwaki Organizes the Signs of Discoid Lupus (DLE) Scarring Alopecia and When to Refer to Specialists2026.07.19

Among patients who visit us worried about thinning hair or increased shedding, some are in fact not experiencing AGA (male-pattern baldness) but a different type of hair loss altogether. Scarring alopecia arising from scalp lesions of collagen disease or systemic lupus erythematosus (SLE) is particularly difficult to distinguish from ordinary thinning in the early stages, and if left untreated, the hair follicles themselves are destroyed and regrowth becomes irreversible. In this article, Dr. Moriwaki organizes the scalp signs that should raise suspicion of hair loss driven by collagen disease — with discoid lupus (DLE) as the representative example — the timing of coordination with dermatology and rheumatology, and the boundaries of indication for hair regenerative medicine including stem cell conditioned media.

Key Points of This Article

・Scarring alopecia is irreversible hair loss in which the follicles themselves are destroyed, fundamentally different from AGA where hairs merely become thinner and shed

・Discoid lupus erythematosus (DLE) predilects the scalp; sharply demarcated round bald patches, central atrophy, loss of follicular ostia, and marginal redness are its hallmark signs

・When collagen disease or lupus is suspected, dermatologic skin biopsy and, when needed, systemic workup by a rheumatologist take top priority

・Hair regenerative medicine is treatment to “protect follicles that can still be saved”; using stem cell conditioned media alone for an active, undiagnosed inflammatory alopecia should be avoided

・Only after inflammation has quieted and systemic management is stabilized should combined use be considered, with the limited goal of improving the scalp environment around the scar

What Is Scarring Alopecia — The Fundamental Difference from AGA

AGA Is a Disease Where Follicles “Shrink”; This Is a Disease Where They Are “Lost”

AGA is a hair loss condition in which the follicles miniaturize under the action of the male hormone (DHT), and hairs become progressively thinner and shorter. Because the follicles themselves remain, there is room for the thinned hairs to grow thick again once the follicular microenvironment is corrected with oral medication, topical agents, or stem cell conditioned media.

By contrast, in scarring hair loss, inflammatory attack on the follicles or chronic inflammation destroys the bulge region — where the follicular stem cells reside — and the dermal papilla. The follicle is replaced by fibrotic scar tissue, and hair will never grow from that area again. The medical principle is that any hair-regrowth treatment is essentially ineffective on “scalp where the follicle has been lost.”

How Collagen Disease and Lupus Affect the Scalp

Collagen disease is a general term for a group of illnesses in which autoimmune abnormality causes the body to attack its own tissues, including systemic lupus erythematosus (SLE), cutaneous lupus erythematosus (CLE), scleroderma, and dermatomyositis. In these diseases, the skin, including the scalp, can be one of the main target organs.

In particular, discoid lupus erythematosus (DLE) is a representative form of chronic cutaneous lupus that prefers sun-exposed sites such as the scalp, face, and ears. When DLE lesions arise on the scalp, active phases involve strong inflammation, and in the chronic phase the follicles become fibrotic and lose the capacity for regrowth. DLE may occur alone, or it may appear as a manifestation of SLE (systemic lupus), in which case systemic symptoms such as renal involvement, arthritis, and hematologic abnormalities are also present.

scarring alopecia lupus DLE scalp

Scalp Signs That Should Raise Suspicion of DLE-Related Hair Loss

Five Points to Notice on Inspection and Palpation

DLE-associated hair loss shows characteristic findings not seen in AGA. When the following signs are present, it should not be treated as simple thinning — a dermatologic workup is needed.

First, the bald patches have sharply demarcated, discoid (coin-shaped) borders. Rather than diffuse thinning like AGA, the loss appears as clearly circular patches. Second, the center of the patch is atrophic, glossy and white, and follicular ostia (the pinpoint hair openings) have disappeared. Healthy scalp shows small pores evenly distributed, but pores close over the scarred area.

Third, the margins show redness, scaling (scale-like flakes), and follicular plugs (keratotic plugs in the pores). Fourth, the condition worsens with sun exposure and is accompanied by itching or mild pain. Fifth, similar rashes also appear on non-scalp areas such as the face, ears, or upper chest. When these findings line up, the likelihood of scarring alopecia from DLE rises.

Course of Symptoms and Coexisting Systemic Symptoms

DLE by itself often follows a chronic course confined to the skin, but in a subset of cases it is known to progress to SLE (systemic lupus). In SLE, in addition to DLE lesions on the scalp, features such as malar rash (redness of the cheeks), photosensitivity, oral ulcers, joint pain, low-grade fever, and nephritic symptoms (edema, hematuria) emerge.

When such systemic symptoms are present, or when there is a family history of collagen disease, autoantibodies including antinuclear antibody must be checked via blood testing. Hair loss on the scalp can at times appear as the “entry point” of a systemic disease, and a rheumatologic workup should take priority before considering hair regenerative medicine.

Deciding on Specialty Referral and the Role of Stem Cell Conditioned Media

When to Coordinate with Dermatology and Rheumatology

When DLE is suspected, the first-line step is a dermatologic diagnosis confirmed by skin biopsy (tissue examination). At the stage where sharply demarcated patches, follicular plugs, and atrophic findings raise suspicion on inspection, referral to dermatology should be prioritized without hesitation. The guidelines of the Japanese Dermatological Association can also serve as reference for dermatologic conditions, but the main pathway for this pathology is differential diagnosis in dermatology.

Furthermore, when systemic symptoms are suspected or antinuclear/anti-DNA antibodies are positive, a workup by a rheumatologist is required. If SLE is diagnosed, systemic treatment such as hydroxychloroquine, steroids, or immunosuppressants is initiated. Topical or intralesional steroids to the scalp are also important treatments to suppress active-phase inflammation and prevent scarring from “progressing further.”

Where Hair Regenerative Medicine Including Stem Cell Conditioned Media Fits

The indication for stem cell conditioned media in scarring alopecia is extremely limited and must be judged with caution. Because no follicles remain in already completed scar tissue, injecting stem cell conditioned media into that area does not produce regrowth. It is necessary to carefully share with patients the principle that “treatment promising regrowth in scarred areas” does not stand up medically.

On the other hand, once inflammation has been completely quieted and systemic control by rheumatology is stable, there is room to combine scalp treatment with stem cell conditioned media for the limited purpose of maintaining healthy follicles remaining around the scar and improving the scalp environment. However, this should only be carried out in coordination with the dermatologist and rheumatologist in charge, and jumping into monotherapy during the active, undiagnosed phase should be avoided.

Hair regenerative medicine is treatment to “protect follicles that can still be saved,” not treatment to “resurrect lost follicles” — a principle that must be held especially firmly in cases like these. For related information, please also see our index of columns on hair regenerative medicine.

Frequently Asked Questions

Q. Can scarring alopecia be improved with AGA treatments?

Because the follicles themselves have been lost, conventional AGA treatments such as finasteride, minoxidil, or stem cell conditioned media are essentially ineffective. The priority is a dermatologic diagnosis and suppression of the inflammation first.

Q. If red, coin-shaped bald patches appear on the scalp, which specialty should I visit?

We recommend visiting dermatology first. For hair loss driven by collagen disease such as discoid lupus erythematosus (DLE), diagnosis by skin biopsy and, when necessary, a systemic workup by rheumatology may be required.

Q. If I am diagnosed with DLE, should I give up on stem cell conditioned media treatment?

It is out of indication during the acute active phase or before treatment. However, once inflammation has quieted under rheumatologic management, limited combined use may be considered — with the goal of maintaining healthy follicles around the scar — after consulting your attending physician.

Q. What happens if it is left untreated?

As long as inflammation persists, the disease continues to progress. The longer it is left, the wider the area of follicle destruction, and the area that will never grow hair again expands. Early dermatologic consultation and inflammation control are essential.

Q. If someone in my family has collagen disease, am I more likely to develop it?

Genetic predisposition is thought to play a role in collagen disease, but it does not mean everyone will develop it. That said, if you have a family history and notice coin-shaped bald patches or redness on your scalp, we recommend early evaluation by dermatology and rheumatology.

──────────────

【Medical Supervisor】Shin Moriwaki (Supervising Physician)

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt available

Inquiries welcome via DM / LINE / Website / Phone.